NASDAQ Composite opens in less than fourteen hours and Catalyst Pharmaceuticals’s premarket value is already 2.54% down.

The last session, NASDAQ Composite finished with Catalyst Pharmaceuticals rising 2.01% to $3.55. NASDAQ Composite rose 2.56% to $13,067.48, following last session’s upward trend on what was an all-around positive trend trading session.

Catalyst Pharmaceuticals’s last close was $3.48, 48.73% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 12.1% for the ongoing quarter and 5.5% for the next. The company’s growth estimates for the current quarter is 37.5% and a drop 10% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $3.55 at 19:39 EST, way below its 52-week high of $5.28 and way above its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is higher than its 50-day moving average of $3.53 and under its 200-day moving average of $3.68.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a negative 0.86%, a positive 0.67%, and a negative 0.14%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 5.33%, 4.87%, and 5.20%, respectively.

LEAVE A REPLY

Please enter your comment!
Please enter your name here